ʻO IceCure Medical Ltd., mea hoʻomohala o ka ʻenehana hou a me ka ʻenehana cryoablasi invasive liʻiliʻi e luku ai i nā tumors ma o ka hau ʻana, ua hoʻolaha ʻia i kēia lā ua komo i loko o kahi ʻaelike hoʻolaha mua me Mobile SCANMED Systems SP. z oo e kūʻai aku wale aku i ka Pūnaewele ʻo ProSense ™ Cryoablation a me nā mea pono ʻole ma Polani. Ma waena o ʻumikūmālua mau mahina o ke kau inoa ʻana i ka ʻaelike hoʻokaʻawale mua, manaʻo nā ʻaoʻao e komo i kahi ʻaelike hoʻokaʻawale kūʻokoʻa lōʻihi.
"Ua hauʻoli mākou e hoʻolaha i ka ʻaelike mua me Mobile SCANMED Systems e hāʻawi i kā mākou ProSense Cryoablation System ma Polani, e hoʻonui ana i kā mākou hiki i ka European Union (ka" EU "), kahi i ʻae ʻia ai kā mākou ʻōnaehana ma lalo o ka māka CE. Kūkulu kēia ʻaelike ma ka pūnaewele hoʻoili a mākou i hoʻokumu ai i loko o ka makahiki i hala a he ʻāpana ia o kā mākou nuʻukia e lawe i kēia ʻenehana i nā kālaihonua āpau, "i ʻōlelo ʻia e Eyal Shamir, Luna Hoʻokele o IceCure. "Ua ʻike ʻia ka ʻōnaehana mālama Polani no ka hoʻolako ʻana i ka maʻi ʻaʻai nui loa a me ka ʻae ʻana i nā hoʻoponopono hou a me nā ʻenehana. ʻOiai ke hoʻomau nei ka maʻi ʻaʻai umauma i ʻano maʻi maʻi ʻaʻai nui i waena o nā wahine Polani, me kahi 24,644 wahine i hōʻike ʻia i ʻike ʻia ma 2020.1, Ua hui pū ʻo Polani i ka hana o ka honua holoʻokoʻa e hoʻonui i ka loiloi ʻana i ka maʻi ʻaʻai umauma i mea e ʻike ai a mālama i nā mea maʻi i nā wā ma mua. Manaʻoʻiʻo mākou ua pili pono kēia pāʻoihana me ka hiki i kā mākou ʻōnaehana e mālama i nā mea maʻi ma mua a me ka ʻole o ke kahakaha ʻana e ka luku ʻana i nā tumors malignant. Hoʻohui ʻia, hāʻawi pū aku kā mākou ʻenehana i kahi minimaly invasive alternative i ke ʻoki ʻana no ka mālama ʻana i ka maʻi ʻaʻai i nā mea ʻē aʻe, e like me ka puʻupaʻa, ka māmā, a me ka iwi. "
"Ke hoʻomau nei ka lawe ʻana o ka hui Mobile SCANMED Systems i kā mākou nuʻukia e hoʻolako i nā lawelawe mālama ola Polani i nā ʻenehana ʻoi loa a me nā ʻenehana hou loa mai ka honua holoʻokoʻa. E lawe mai ka ʻaelike o kēia lā i ka ʻenehana cryoablization hou a ka ProSense Cryoablation System i nā mea maʻi maʻi umauma ma Polani. Hiki i ka ProSense Cryoablation System ke luku i nā tumors me ka palekana, wikiwiki, a me ka ʻeha ʻole, me ka ʻole o ke ʻoki ʻana, "i ʻōlelo ʻo Marcin Weksler, Luna Hoʻokele o Mobile SCANMED Systems.
Ma lalo o nā ʻōlelo o ka ʻaelike hoʻolaha mua, e kuleana ʻo Mobile SCANMED Systems e hoʻoponopono i nā koi āpau e kūʻai aku ai i ka ProSense Cryoablation System ma Polani. E kūʻai wale aku paha nā Pūnaewele SCANMED Mobile ma Polani i nā huahana ProSense Cryoblation System a me nā mea kūʻai aku i kūʻai ʻia mai IceCure. Ma hope o ke kau inoa ʻana i ka ʻaelike hoʻolaha mua, e hoʻonohonoho pū ʻo Mobile SCANMED Systems i kahi kauoha kūʻai mua e pili ana i $ 100,000.
He aha e lawe ʻia mai kēia ʻatikala:
- As breast cancer continues to be one of the most common types of cancer among Polish women, with a reported 24,644 women diagnosed in 20201, Poland has joined the global effort to increase breast cancer screening in order to diagnose and treat patients at earlier stages.
- “We are excited to announce the initial agreement with Mobile SCANMED Systems to distribute our ProSense Cryoablation System in Poland, expanding our reach in the European Union (the “EU”), where our system is currently approved under CE mark.
- This agreement builds on the distribution network we’ve established over the past year and is a part of our mission to bring this technology to all geographies,”.
